Literature DB >> 18237108

Prodrugs of phosphates and phosphonates.

Scott J Hecker1, Mark D Erion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18237108     DOI： 10.1021/jm701260b

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  59 in total

1.  Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.

Authors:  Ilia Korboukh; Emily A Hull-Ryde; Joseph E Rittiner; Amarjit S Randhawa; Jennifer Coleman; Brendan J Fitzpatrick; Vincent Setola; William P Janzen; Stephen V Frye; Mark J Zylka; Jian Jin
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  Ribonuclease-Activated Cancer Prodrug.

Authors:  Gregory A Ellis; Nicholas A McGrath; Michael J Palte; Ronald T Raines
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

3.  Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.

Authors:  Wen-Jian Qian; Terrence R Burke
Journal:  Amino Acids       Date:  2013-08-02       Impact factor: 3.520

4.  Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs.

Authors:  Wen-Jian Qian; Jung-Eun Park; Dan Lim; Suk-Youl Park; Ki-Won Lee; Michael B Yaffe; Kyung S Lee; Terrence R Burke
Journal:  Chem Biol       Date:  2013-10-10

Review 5.  Advances in nucleoside monophosphate prodrugs as anti-HCV agents.

Authors:  Drew R Bobeck; Raymond F Schinazi; Steven J Coats
Journal:  Antivir Ther       Date:  2010

6.  Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives.

Authors:  Jian-Bing Shen; Kiran S Toti; Saibal Chakraborty; T Santhosh Kumar; Chunxia Cronin; Bruce T Liang; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2020-01-27       Impact factor: 3.765

7.  Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.

Authors:  Ramu Rondla; Steven J Coats; Tamara R McBrayer; Jason Grier; Melissa Johns; Phillip M Tharnish; Tony Whitaker; Longhu Zhou; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

8.  Potent inhibitors of a shikimate pathway enzyme from Mycobacterium tuberculosis: combining mechanism- and modeling-based design.

Authors:  Sebastian Reichau; Wanting Jiao; Scott R Walker; Richard D Hutton; Edward N Baker; Emily J Parker
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

Review 9.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

Review 10.  Phosphonate prodrugs: an overview and recent advances.

Authors:  Kenneth M Heidel; Cynthia S Dowd
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.